ArticleMedicine2025
Association between ALBI score and stroke risk and all-cause mortality: 2011 to 2018 NHANES.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The relationship between the albumin-bilirubin (ALBI) score and stroke risk and all-cause mortality has not been fully established, and this study aims to explore the potential links between them. This study analyzed data from the 2011 to 2018 National Health and Nutrition Examination Survey to examine the association between the ALBI score and stroke risk. Logistic regression and subgroup analyses were conducted. A restricted cubic spline analysis was conducted to assess potential nonlinear associations. Survival outcomes were estimated using Kaplan-Meier curves and Cox proportional hazards models. In the fully adjusted model, each 1-unit increase in the ALBI score was linked to an estimated 2.60-fold rise in stroke risk (OR = 2.60, 95% CI: 1.80-3.75, P < .001). The association was particularly strong in older individuals, participants without diabetes, and those who never consumed alcohol. Restricted cubic spline analysis demonstrated a linear association between the ALBI score and stroke risk after adjusting for confounders. In addition, a higher ALBI was associated with a higher risk of all-cause mortality (OR = 2.39, 95% CI: 1.84-3.11, P < .001), and this association was stronger in patients without stroke. Kaplan-Meier curves showed a clear trend between ALBI quartiles (P < .001). A higher ALBI score is linked to a greater risk of stroke and mortality. These findings highlight the importance of liver function in cerebrovascular pathology.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.